STOCK TITAN

Expensify (EXFY) files preliminary results for $25M tender offer

(Neutral)
(Neutral)
Form Type
SC TO-I/A

Rhea-AI Filing Summary

Expensify, Inc. amended its Schedule TO to report preliminary results for its cash tender offer to purchase up to $25,000,000 of Class A common stock at a per-share price between $0.98 and $1.20. The tender offer expired at 12:00 midnight, New York City time, at the end of the day on June 10, 2026.

The amendment states a press release announcing preliminary results was issued on June 11, 2026 and is filed as Exhibit (a)(5)(ii).

Positive

  • None.

Negative

  • None.

Insights

Cash tender for up to $25,000,000 reported; preliminary results filed.

Expensify amended its Schedule TO to add a press release dated June 11, 2026 reporting preliminary results of the tender offer to buy up to $25,000,000 of Class A common stock at $0.98–$1.20 per share.

The filing confirms the offer expired at June 10, 2026; further details on shares validly tendered and purchases will appear in the preliminary results exhibit.

Administrative amendment adds preliminary-results press release as an exhibit.

The Schedule TO amendment does not change offer terms; it incorporates by reference a press release filed as Exhibit (a)(5)(ii) announcing preliminary results following the June 10, 2026 expiration.

Cash‑flow treatment and final purchase amounts are subject to the preliminary-results disclosure and any subsequent settlement statements.

Tender offer size $25,000,000 aggregate cash amount offered
Price range $0.98 - $1.20 per share offer price per share range stated in Schedule TO
Offer expiration June 10, 2026 offer expired at 12:00 midnight, New York City time
Preliminary results press release June 11, 2026 date of press release filed as Exhibit (a)(5)(ii)
tender offer financial
"to purchase for cash up to $25,000,000 of its Class A common stock"
A tender offer is a proposal made by a person or company to buy shares from existing shareholders at a set price, usually higher than the current market value, within a specific time frame. It matters to investors because it can lead to a change in ownership or control of a company, and shareholders must decide whether to sell their shares at the offered price.
Schedule TO regulatory
"Tender Offer Statement on Schedule TO originally filed with the Securities and Exchange Commission"
A phrase indicating that a company plans or intends to hold an event, publish information, or take an action at a specified future time, but that the timing is not guaranteed and may change. For investors it signals an expected milestone—like an earnings call, product launch, or filing—so think of it as a calendar note rather than a firm promise; timing shifts can affect trading, expectations, and planning.
Offer to Purchase financial
"terms and subject to the conditions described in the Offer to Purchase, dated May 13, 2026"
An offer to purchase is a formal proposal from one party to buy a specific amount of shares or assets from another party at a set price. It matters to investors because it signals interest in acquiring ownership and can influence the value or control of a company. Think of it as someone putting forward a clear, serious offer to buy something they find valuable.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
 
SECURITIES AND EXCHANGE COMMISSION 
Washington, D.C. 20549
 
Amendment No. 2
SCHEDULE TO
Tender Offer Statement under Section 14(d)(1) or 13(e)(1)
of the Securities Exchange Act of 1934
  
Expensify, Inc.
(Name of Subject Company (Issuer))
 
Expensify, Inc.
(Names of filing Persons (Offeror and Issuer))
  
Class A Common Stock, Par Value $0.0001 per share
(Title of Class of Securities)
30219Q106
(CUSIP Number of Class of Securities)
(Underlying Common Stock)
  
Ryan Schaffer
Chief Financial Officer
Expensify, Inc.
88 Kearny St., Ste 1600
San Francisco, California 94108
Tel: (971) 365-3939
(Name, address and telephone number of person authorized to receive notices and communications on behalf of filing person)
  
Copies to:
Tad J. Freese, Esq.
Alexa M. Berlin, Esq.
Latham & Watkins LLP
140 Scott Drive
Menlo Park, California 94025
(650) 328-4600
Joshua A. Kaufman, Esq.
DLA Piper LLP (US)
1251 Avenue of the Americas
New York, NY 10020
☐ Check the box if the filing relates solely to preliminary communications made before the commencement of a tender offer.
Check the appropriate boxes below to designate any transactions to which the statement relates:
Third-party tender offer subject to Rule 14d-1.
Issuer tender offer subject to Rule 13e-4.
Going-private transaction subject to Rule 13e-3.
Amendment to Schedule 13D under Rule 13d-2.
Check the following box if the filing is a final amendment reporting the results of the tender offer: ☐
If applicable, check the appropriate box(es) below to designate the appropriate rule provision(s) relied upon:
Rule 13e-4(i) (Cross-Border Issuer Tender Offer) 
Rule 14d-1(d) (Cross-Border Third-Party Tender Offer)
This Amendment No. 2 (this “Amendment No. 2”) amends and supplements the Tender Offer Statement on
Schedule TO originally filed with the Securities and Exchange Commission (the “Commission”) on May 13, 2026,
as amended and supplemented by Amendment No. 1 to the Tender Offer Statement on Schedule TO filed with the
Commission on May 29, 2026 (the “Schedule TO”),  related to the offer by Expensify, Inc., a Delaware corporation
(the “Company”), to purchase for cash up to $25,000,000 of its Class A common stock, par value $0.0001 per share,
at a price per share of not less than $0.98 and not more than $1.20, without interest and subject to any applicable
withholding taxes. The Company’s offer is made upon the terms and subject to the conditions described in the Offer
to Purchase, dated May 13, 2026 (as amended or supplemented from time to time, the “Offer to Purchase”), a copy
of which was filed as Exhibit (a)(1)(i) to the Schedule TO, and in the accompanying Letter of Transmittal (as
amended or supplemented from time to time, the “Letter of Transmittal” and, the Letter of Transmittal together with
the Offer to Purchase, the “tender offer”), a copy of which was attached as Exhibit (a)(1)(ii) to the Schedule TO.
Except as specifically provided herein, the information contained in the Schedule TO remains unchanged and this
Amendment No. 2 does not modify any of the information previously reported on the Schedule TO. You should read
this Amendment No. 2 together with the Schedule TO, the Offer to Purchase and the Letter of Transmittal.
The Schedule TO is hereby amended and supplemented as follows:
Item 11.                           Additional Information.
 
The information set forth in Item 11 is hereby amended and supplemented by adding the following:
“On June 11, 2026, the Company issued a press release announcing the preliminary results of the tender offer, which
expired at 12:00 midnight, New York City time, at the end of the day on June 10, 2026. A copy of the press release
is filed as Exhibit (a)(5)(ii) hereto and is incorporated by reference herein.”
 
Item 12.                         Exhibits.
Item 12 of the Schedule TO is hereby amended and supplemented by adding the following exhibit:
EXHIBIT
NUMBER
DESCRIPTION
(a)(5)(ii)*
Press release announcing the preliminary results of the tender offer, dated June 11, 2026.
* Filed herewith
SIGNATURES
 
After due inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement
is true, complete and correct.
 
Dated: June 11, 2026
EXPENSIFY, INC.
By:
/s/ Ryan Schaffer
Name:
Ryan Schaffer
Title:
Chief Financial Officer